Tumor budding in colorectal carcinoma: time to take notice (Q34287716)

1 August 2017

title

Tumor budding in colorectal carcinoma: time to take notice (English)

1 reference

1 August 2017

1 reference

Bojana Mitrovic

1

1 reference

1 August 2017

David F Schaeffer

series ordinal

2

1 reference

1 August 2017

Robert H Riddell

series ordinal

3

1 reference

1 August 2017

Richard Kirsch

series ordinal

4

1 reference

1 August 2017

publication date

13 July 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

25

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1315-1325

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.94

1 August 2017

exact match

0 references

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

A perspective on cancer cell metastasis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

EMT: when epithelial cells decide to become mesenchymal-like cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

The basics of epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor dedifferentiation: an important step in tumor invasion.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tubular invasion and the morphogenesis of tumor budding in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding as a prognostic marker in stage-III rectal carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Intensity of tumor budding as an index for the malignant potential in invasive rectal carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Prognostic value of tumor "budding" in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Risk factors of nodal involvement in T2 colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding and evidence-based treatment of T2 rectal carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Risk factors for an adverse outcome in early invasive colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

A new prognostic staging system for rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Pathological predictors for lymph node metastasis in T1 colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Budding as a useful prognostic marker in pT3 well‐ or moderately‐differentiated rectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding as an index to identify high-risk patients with stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumour budding as prognostic factor in stage I/II colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Histological categorisation of fibrotic cancer stroma in advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumour budding correlates with local recurrence of rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Management of early rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Histopathologic determinants of regional lymph node metastasis in early colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Randomised trials of HIV prevention

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding and survival after potentially curative resection of node-positive colon cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

APC mutation and tumour budding in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Newer pathologic assessment techniques for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.94

7 January 2021

10.1038/MODPATHOL.2012.94

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1053715736

0 references

1 reference